Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.

Duman RS, Voleti B.

Trends Neurosci. 2012 Jan;35(1):47-56. doi: 10.1016/j.tins.2011.11.004. Review.

2.

Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections.

Duman RS.

Depress Anxiety. 2014 Apr;31(4):291-6. doi: 10.1002/da.22227. Epub 2014 Mar 10. Review.

3.

A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.

Duman RS, Li N.

Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2475-84. doi: 10.1098/rstb.2011.0357. Review.

4.

The roles of neurotrophic factor and Wnt signaling in depression.

Voleti B, Duman RS.

Clin Pharmacol Ther. 2012 Feb;91(2):333-8. doi: 10.1038/clpt.2011.296. Epub 2011 Dec 28. Review.

PMID:
22205198
5.

The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.

Masi G, Brovedani P.

CNS Drugs. 2011 Nov 1;25(11):913-31. doi: 10.2165/11595900-000000000-00000. Review.

PMID:
22054117
6.

Cell atrophy and loss in depression: reversal by antidepressant treatment.

Banasr M, Dwyer JM, Duman RS.

Curr Opin Cell Biol. 2011 Dec;23(6):730-7. doi: 10.1016/j.ceb.2011.09.002. Epub 2011 Oct 11. Review.

7.

A molecular and cellular theory of depression.

Duman RS, Heninger GR, Nestler EJ.

Arch Gen Psychiatry. 1997 Jul;54(7):597-606. Review.

PMID:
9236543
8.

Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies.

Drzyzga ŁR, Marcinowska A, Obuchowicz E.

Brain Res Bull. 2009 Jun 30;79(5):248-57. doi: 10.1016/j.brainresbull.2009.03.009. Epub 2009 Apr 5. Review.

PMID:
19480984
9.

A neurotrophic model for stress-related mood disorders.

Duman RS, Monteggia LM.

Biol Psychiatry. 2006 Jun 15;59(12):1116-27. Epub 2006 Apr 21. Review.

PMID:
16631126
10.

A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.

Naughton M, Clarke G, O'Leary OF, Cryan JF, Dinan TG.

J Affect Disord. 2014 Mar;156:24-35. doi: 10.1016/j.jad.2013.11.014. Epub 2013 Dec 10. Review.

PMID:
24388038
11.

Role of neurotrophic factors in the etiology and treatment of mood disorders.

Duman RS.

Neuromolecular Med. 2004;5(1):11-25. Review.

PMID:
15001809
12.

Depression research: where are we now?

Lee S, Jeong J, Kwak Y, Park SK.

Mol Brain. 2010 Mar 10;3:8. doi: 10.1186/1756-6606-3-8. Review.

13.

[Ketamine's antidepressant effect: focus on ketamine mechanisms of action].

De Maricourt P, Jay T, Goncalvès P, Lôo H, Gaillard R.

Encephale. 2014 Feb;40(1):48-55. doi: 10.1016/j.encep.2013.09.002. Epub 2014 Jan 13. Review. French.

PMID:
24434007
14.

Role of neurotrophic factors in depression.

Castrén E, Võikar V, Rantamäki T.

Curr Opin Pharmacol. 2007 Feb;7(1):18-21. Epub 2006 Oct 17. Review.

PMID:
17049922
15.

Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders.

Manji HK, Chen G.

Curr Psychiatry Rep. 2000 Dec;2(6):479-89. Review.

PMID:
11122999
16.

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, A Gray N, Zarate CA Jr, Charney DS.

Biol Psychiatry. 2003 Apr 15;53(8):707-42. Review.

PMID:
12706957
17.

[The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data].

Paslakis G, Gass P, Deuschle M.

Fortschr Neurol Psychiatr. 2011 Apr;79(4):204-12. doi: 10.1055/s-0029-1245770. Epub 2010 Nov 29. Review. German.

PMID:
21117011
18.

Metabotropic glutamate receptors in the control of mood disorders.

Witkin JM, Marek GJ, Johnson BG, Schoepp DD.

CNS Neurol Disord Drug Targets. 2007 Apr;6(2):87-100. Review.

PMID:
17430147
19.

Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes.

Duric V, Duman RS.

Cell Mol Life Sci. 2013 Jan;70(1):39-53. doi: 10.1007/s00018-012-1020-7. Epub 2012 May 15. Review.

20.

Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior.

Mann JJ.

Neuropsychopharmacology. 1999 Aug;21(2 Suppl):99S-105S. Review.

Supplemental Content

Support Center